Parallel Advisors LLC Buys More Pfizer Shares as Earnings Beat
NewEdge Advisors LLC increased its Pfizer stake by 0.5% in the first quarter, owning 712,319 shares worth $20.0 million after buying more shares. Blue Edge Capital LLC and Flagship Wealth Advisors LLC also raised positions. Pfizer reported $0.77 EPS, beating consensus, on $15.03 billion revenue, and raised its 2026 revenue outlook.